Pharmaceutical Research Associates Taiwan

Pharmaceutical Research Associates Taiwan, now integrated into ICON plc, is a leading contract research organization (CRO) providing comprehensive clinical development services in Taiwan and the broader Asia-Pacific region. The company supports pharmaceutical, biotechnology, and medical device clients through all phases of clinical research, from early-stage trials to post-marketing studies. Its service portfolio includes clinical trial management, regulatory consulting, site monitoring, and data analytics tailored to the local regulatory environment. Following its acquisition by ICON in 2021, the Taiwan branch leverages an expanded global network and advanced digital health technologies to support decentralized and hybrid clinical trials. The organization maintains a strong focus on complex therapeutic areas such as oncology, cardiovascular disease, and infectious diseases.